Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Clinical impact of vancomycin-resistant enterococci Patel RJ Antimicrob Chemother 2003[Jun]; 51 Suppl 3 (ä): iii13-21In humans, vancomycin-resistant enterococci (VRE) most commonly result in intestinal colonization, which does not result in symptoms, may persist for a long time and serves as a reservoir for transmission of VRE to other patients. Certain VRE-colonized patients are at risk of infection, including haematology and oncology patients, patients in intensive care units and recipients of solid (especially abdominal) organ transplants. Controlling the spread of VRE colonization and preventing colonized patients from becoming infected are important aims. Ramoplanin is a member of a new class of antimicrobial agents; it may have a role in preventing infection in patients colonized with VRE.|*Depsipeptides[MESH]|Anti-Bacterial Agents/*therapeutic use[MESH]|Cross Infection/*prevention & control/transmission[MESH]|Enterococcus/classification/*drug effects/genetics[MESH]|Gram-Positive Bacterial Infections/*prevention & control/transmission[MESH]|Humans[MESH]|Infection Control[MESH]|Peptides, Cyclic/*therapeutic use[MESH]|Vancomycin Resistance/*genetics[MESH] |